🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate anti-PD-1 Neoadjuvant therapy in B...
Status
Completed
Location
Cleveland Clinic, Case Comprehensive Cancer Center
Start Date
2020-08-04
Trial ID
NCT04323202
Treatments Being Tested
This clinical trial tests the feasibility and utility of a biology guided t...
Status
Not Yet Recruiting
Location
City of Hope Medical Center
Start Date
2026-12-19
Trial ID
NCT07590583
This study aims to assess the outcome of standardized evidence-based care t...
Status
Completed
Location
Zagazig University Faculty of Human Medicine
Start Date
2017-05-15
Trial ID
NCT04615702
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, dosimetr...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2024-09-08
Trial ID
NCT06376253
Treatments Being Tested
The purpose of this study is to evaluate this AngioScan angiography softwar...
Status
Terminated
Location
Stein Eye Institute/Geffen School of Medicine
Start Date
2016-07
Trial ID
NCT02827071
RATIONALE: Biological therapies, such as tumor necrosis factor, may stimula...
Status
Completed
Location
NCI - Center for Cancer Research-Medical Oncology
Start Date
2006-12
Trial ID
NCT00436410
The purpose of this clinical study is to collect performance and safety dat...
Status
Recruiting
Location
University of Arizona
Start Date
2023-05-01
Trial ID
NCT05856370
Treatments Being Tested
RATIONALE: Vatalanib and pemetrexed disodium may stop the growth of tumor c...
Status
Completed
Location
Mayo Clinic
Start Date
2007-01-25
Trial ID
NCT00390000
Treatments Being Tested
The purpose of this study is to compare the two different saphenous vein ca...
Status
Completed
Location
University of Iowa Hospitals & Clinics
Start Date
2013-07
Trial ID
NCT01924975
Pemetrexed has demonstrated a favorable response with minimal toxicity when...
Status
Completed
Location
Asan Medical Center
Start Date
2008-07
Trial ID
NCT01490437
Treatments Being Tested